These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 32565215)

  • 1. PRECIS-2 for retrospective assessment of RCTs in systematic reviews.
    Zwarenstein M; Thorpe K; Treweek S; Loudon K
    J Clin Epidemiol; 2020 Oct; 126():202-206. PubMed ID: 32565215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Real-world evidence: How pragmatic are randomized controlled trials labeled as pragmatic?
    Dal-Ré R; Janiaud P; Ioannidis JPA
    BMC Med; 2018 Apr; 16(1):49. PubMed ID: 29615035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The PRECIS-2 tool: designing trials that are fit for purpose].
    Hu GP; Zhan SY
    Zhonghua Liu Xing Bing Xue Za Zhi; 2018 Feb; 39(2):222-226. PubMed ID: 29495210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pragmatic vs. explanatory: an adaptation of the PRECIS tool helps to judge the applicability of systematic reviews for daily practice.
    Koppenaal T; Linmans J; Knottnerus JA; Spigt M
    J Clin Epidemiol; 2011 Oct; 64(10):1095-101. PubMed ID: 21474282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The design can limit PRECIS-2 retrospective assessment of the clinical trial explanatory/pragmatic features.
    Dal-Ré R; de Boer A; James SK
    J Clin Epidemiol; 2020 Oct; 126():193-201. PubMed ID: 32325221
    [No Abstract]   [Full Text] [Related]  

  • 6. The role of pragmatism in explaining heterogeneity in meta-analyses of randomised trials: a protocol for a cross-sectional methodological review.
    Aves T; Allan KS; Lawson D; Nieuwlaat R; Beyene J; Mbuagbaw L
    BMJ Open; 2017 Sep; 7(9):e017887. PubMed ID: 28871028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Articles provided insufficient information to conduct an appropriate retrospective assessment of the pragmatic/explanatory features of medicine trials with the PRECIS-2 tool.
    Dal-Ré R
    Eur J Clin Pharmacol; 2020 Aug; 76(8):1093-1102. PubMed ID: 32447436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized controlled trials and neurosurgery: the ideal fit or should alternative methodologies be considered?
    Mansouri A; Cooper B; Shin SM; Kondziolka D
    J Neurosurg; 2016 Feb; 124(2):558-68. PubMed ID: 26315006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A dynamic application of PRECIS-2 to evaluate implementation in a pragmatic, cluster randomized clinical trial in two nursing home systems.
    Palmer JA; Mor V; Volandes AE; McCreedy E; Loomer L; Carter P; Dvorchak F; Mitchell SL
    Trials; 2018 Aug; 19(1):453. PubMed ID: 30134976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do randomized controlled nursing trials have a pragmatic or explanatory attitude? Findings from the Pragmatic-Explanatory Continuum Indicator Summary (PRECIS) tool exercise.
    Palese A; Bevilacqua MG; Dante A;
    J Nurs Res; 2014 Sep; 22(3):216-20. PubMed ID: 25111115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic Review and Meta-Analysis of Randomised, Other-than-Placebo Controlled, Trials of Individualised Homeopathic Treatment.
    Mathie RT; Ulbrich-Zürni S; Viksveen P; Roberts ER; Baitson ES; Legg LA; Davidson JRT
    Homeopathy; 2018 Nov; 107(4):229-243. PubMed ID: 30121049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Progress in research of pragmatic-explanatory continuum indicator summary].
    Hu G; Hu Y; Zhan S
    Zhonghua Liu Xing Bing Xue Za Zhi; 2016 Mar; 37(3):439-42. PubMed ID: 27005554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The PRECIS-2 tool seems not to be useful to discriminate the degree of pragmatism of medicine masked trials from that of open-label trials.
    Dal-Ré R
    Eur J Clin Pharmacol; 2021 Apr; 77(4):539-546. PubMed ID: 33106910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The PRECIS-2 tool has good interrater reliability and modest discriminant validity.
    Loudon K; Zwarenstein M; Sullivan FM; Donnan PT; Gágyor I; Hobbelen HJSM; Althabe F; Krishnan JA; Treweek S
    J Clin Epidemiol; 2017 Aug; 88():113-121. PubMed ID: 28603007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Understanding the applicability of results from primary care trials: lessons learned from applying PRECIS-2.
    Forbes G; Loudon K; Treweek S; Taylor SJC; Eldridge S
    J Clin Epidemiol; 2017 Oct; 90():119-126. PubMed ID: 28629699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of blinding on estimates of mortality in randomised clinical trials of intensive care interventions: protocol for a systematic review and meta-analysis.
    Anthon CT; Granholm A; Perner A; Laake JH; Møller MH
    BMJ Open; 2017 Jul; 7(7):e016187. PubMed ID: 28701412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrating pragmatic and implementation science randomized clinical trial approaches: a PRagmatic Explanatory Continuum Indicator Summary-2 (PRECIS-2) analysis.
    Zatzick D; Palinkas L; Chambers DA; Whiteside L; Moloney K; Engstrom A; Prater L; Russo J; Wang J; Abu K; Iles-Shih M; Bulger E
    Trials; 2023 Apr; 24(1):288. PubMed ID: 37085877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Designing provider-focused implementation trials with purpose and intent: introducing the PRECIS-2-PS tool.
    Norton WE; Loudon K; Chambers DA; Zwarenstein M
    Implement Sci; 2021 Jan; 16(1):7. PubMed ID: 33413489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An application of PRECIS-2 to evaluate trial design in a pilot cluster randomised controlled trial of a community-based smoking cessation intervention for women living in disadvantaged areas of Ireland.
    Darker C; Loudon K; O'Connell N; Castello S; Burke E; Vance J; Reynolds C; Buggy A; Dougall N; Williams P; Dobbie F; Bauld L; Hayes CB
    Pilot Feasibility Stud; 2022 Jan; 8(1):19. PubMed ID: 35078530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic Review and Meta-Analysis of Randomised, Other-than-Placebo Controlled, Trials of Non-Individualised Homeopathic Treatment.
    Mathie RT; Fok YYY; Viksveen P; To AKL; Davidson JRT
    Homeopathy; 2019 May; 108(2):88-101. PubMed ID: 30699444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.